Echo Bio
Echo Neurotechnologies is a startup focused on Brain-Computer Interface devices that combines hardware engineering and AI to improve quality of life for people with disabilities. The company emphasizes innovation, collaboration, and continuous growth within a dynamic, early-stage environment.
Echo Bio is a biotechnology company focused on developing advanced tools and platforms for biological research and healthcare applications. The company works at the intersection of life sciences, engineering, and data to support better analysis, diagnostics, or laboratory workflows. Echo Bio operates in the biotechnology industry, building technology that helps researchers and healthcare organizations work more effectively.
Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to advance Immuno-Oncology and Regenerative Cell Therapies
Jan 13, 2026
Heart failure cell therapy shows less adverse cardiac remodeling
2 weeks ago
Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
Jan 13, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Echo Bio.
SCIEX announces Echo® MS+ system integration with ZenoTOF 8600 system, delivering enhanced sensitivity for high-throughput screening
1 month ago